<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">LINCOMYCIN HYDROCHLORIDE</span><br/>(lin-koe-mye'sin)<br/><span class="topboxtradename">Lincocin<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">clindamycin antibiotic</span><br/><b>Prototype: </b>Clindamycin<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>500 mg capsules; 300 mg injection</p>
<h1><a name="action">Actions</a></h1>
<p>Derived from <i>Streptomyces lincolnensis.</i> Similar to clindamycin in antibacterial activity and demonstrates some cross-resistance with it. Bacteriostatic or bactericidal
         depending on concentration used and sensitivity of organism.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effective against most of the common gram-positive pathogens, particularly streptococci, pneumococci, and staphylococci. Also
         effective against Bacteroides and other anaerobes; however, it has little activity against most gram-negative organisms and
         ineffective against viruses, yeasts, or fungi. Resistance by <i>Staphylococcus</i> is acquired in stepwise manner.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Reserved for treatment of serious infections caused by susceptible bacteria in penicillin-allergic patients or patients for
         whom penicillin is inappropriate.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Previous hypersensitivity to lincomycin and clindamycin; impaired liver function, known monilial infections (unless treated
         concurrently); use in newborns. Safe use in pregnancy (category B) or lactation is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Impaired kidney function; history of GI disease, particularly colitis; history of liver, endocrine, or metabolic diseases;
         history of asthma, hay fever, eczema, drug or other allergies; older adult patients.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 500 mg q68h (max: 8 g/d) <span class="rdroute">IM</span> 600 mg q1224 h <span class="rdroute">IV</span> 600 mg1 g q812h<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> &gt;<i>1 mo</i>, 3060 mg/kg in 34 divided doses <span class="rdroute">IM</span> 10 mg/kg q1224h <span class="rdroute">IV</span> 1020 mg/kg/d in 23 divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral/</span><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give with a full glass [240 mL (8 oz)] of water at least 1 h before or 2 h after meals; absorption is reduced and delayed
            by presence of food in stomach.
         </li>
<li>Give injection deep into large muscle mass; inject slowly to minimize pain. Rotate injection sites.</li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Intermittent:</span> Dilute 1 g of lincomycin in at least 100 mL of D5W, NS, or other compatible solution.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Intermittent:</span> Give at a rate <img src="../images/special/lesserorequal.gif"/>1 g/h.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span>
<b>Penicillin G,</b>
<b>phenytoin,</b>
<b>ampicillin,</b>
<b>carbenicillin,</b>
<b>methicillin.</b>
</p>
</td>
</tr>
</table>
<ul>
<li>Follow manufacturer's directions for further information on reconstitution, storage time, compatible IV fluids, and IV administration
            rates.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Hypersensitivity (pruritus, urticaria, skin rashes, exfoliative and vesiculobullous dermatitis, erythema multiforme [rare],
      angioedema, photosensitivity, <span class="speceff-life">anaphylactoid reaction</span>, serum sickness); superinfections (proctitis, pruritus ani, vaginitis); vertigo, dizziness, headache, generalized myalgia,
      thrombophlebitis following IV use; pain at IM injection site. <span class="typehead">CV:</span> Hypotension, syncope, <span class="speceff-life">cardiopulmonary arrest</span> (particularly after rapid IV). <span class="typehead">GI:</span> Glossitis, stomatitis, <span class="speceff-common">nausea, vomiting,</span> anorexia, decreased taste acuity, unpleasant or altered taste, abdominal cramps, <span class="speceff-common">diarrhea,</span> acute enterocolitis, <span class="speceff-life">pseudomembranous colitis (potentially fatal)</span>. <span class="typehead">Hematologic:</span> Neutropenia, leukopenia, <span class="speceff-life">agranulocytosis</span>, thrombocytopenic purpura, <span class="speceff-life">aplastic anemia</span>. <span class="typehead">Special Senses:</span> Tinnitus. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Kaolin and pectin</b> decreases lincomycin absorption; <b>tubocurarine,</b>
<b>pancuronium</b> may enhance neuromuscular blockade. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Partially absorbed from GI tract (2030%). <span class="typehead">Peak:</span> 24 h PO; 30 min IM. <span class="typehead">Duration:</span> 68 h PO; 1214 h IM; 14 h IV. <span class="typehead">Distribution:</span> High concentrations in bone, aqueous humor, bile, and peritoneal, pleural, and synovial fluids; crosses placenta; distributed
      into breast milk. <span class="typehead">Metabolism:</span> Partially metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine and feces. <span class="typehead">Half-Life:</span> 5 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Perform C&amp;S initially and during therapy to determine continued microbial susceptibility. Periodic liver &amp; kidney
            function tests and CBC are indicated during prolonged drug therapy.
         </li>
<li>Take a careful history of previous sensitivities to drugs or other allergens.</li>
<li>Monitor BP and pulse. Have patient remain recumbent following drug administration until BP stabilizes.</li>
<li>Monitor closely and report changes in bowel frequency. Discontinue drug if significant diarrhea occurs.</li>
<li>Diarrhea, acute colitis, or pseudomembranous colitis (see Appendix F) may occur up to several weeks after cessation of therapy.</li>
<li>Examine IM/IV injection sites daily for signs of inflammation.</li>
<li>Monitor serum drug levels closely in patients with severe impairment of kidney function (levels tend to be higher).</li>
<li>Superinfections by nonsusceptible organisms are most likely to occur when duration of therapy exceeds 10 d (see Appendix F).</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Notify physician immediately of symptoms of hypersensitivity (see Appendix F). Drug should be discontinued.</li>
<li>Notify physician promptly of the onset of perianal irritation, diarrhea, or blood and mucus in stools. Do not self-medicate
            for diarrheaanti-diarrheal agents may prolong and worsen diarrhea by delaying removal of toxins from colon.
         </li>
<li>Take drug as prescribed for full course of therapy.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>